Oncology & Cancer

Clinical trial finds new class of cancer drugs safe and effective

The safety and preliminary efficacy of a new class of tumor fighting drugs were reported today by Scottsdale Healthcare's Virginia G. Piper Cancer Center Clinical Trials and the Translational Genomics Research Institute (TGen).

Oncology & Cancer

Research team uncovers root cause of multiple myeloma relapse

Researchers have discovered why multiple myeloma, a difficult to cure cancer of the bone marrow, frequently recurs after an initially effective treatment that can keep the disease at bay for up to several years.

Diseases, Conditions, Syndromes

TGen and NAU patent for new pandemic flu test is approved

The federal government has awarded a patent to the Translational Genomics Research Institute (TGen) and Northern Arizona University (NAU) for a test that can detect—and assist in the treatment of—the H1N1 pandemic flu ...

Genetics

Longevity scores show signs of resilience to certain diseases

Using data from four studies that connect genetic variants to lifespan, scientists have developed 11 different polygenic longevity scores (PLS) that predict both long life and resilience to some age-related conditions such ...

Genetics

Genome sequencing illuminates rare Aicardi syndrome

As my inbox fills with ever more updates on the number of human genomes sequenced and the plummeting time and cost of next next next generation sequencing, I find myself hitting delete more and more often. Instead, I'm drawn ...

page 5 from 7